Global Meningococcal Vaccine Market By Type (Quadrivalent , and Bivalent), By Application (Pneumonia , Meningitis , Bacteremia , and (Arthritis, Conjunctivitis, Urethritis)), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

Published date: Nov 2021
Report ID: 21232
Number of Pages: 260
Format:

- - 1. Meningococcal Vaccine Market Introduction
    1.1. Definition
    1.2. Taxonomy
    1.3. Research Scope
  - 2. Executive Summary
    2.1. Key Findings by Major Segments
    2.2. Top strategies by Major Players
  - 3. Global Meningococcal Vaccine Market Overview
    3.1. Meningococcal Vaccine Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
    3.2. PESTLE Analysis
    3.3. Opportunity Map Analysis
    3.4. PORTER'S Five Forces Analysis
    3.5. Market Competition Scenario Analysis
    3.6. Product Life Cycle Analysis
    3.7. Opportunity Orbits
    3.8. Manufacturer Intensity Map
  - 4. Global Meningococcal Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    4.1. Global Meningococcal Vaccine Market Analysis by Type: Introduction
    4.2. Market Size and Forecast by Region
    4.3. Quadrivalent
    4.4. Bivalent
  - 5. Global Meningococcal Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    5.1. Global Meningococcal Vaccine Market Analysis by Application: Introduction
    5.2. Market Size and Forecast by Region
    5.3. Pneumonia
    5.4. Meningitis
    5.5. Bacteremia
    5.6. (Arthritis, Conjunctivitis, Urethritis)
  - 6. Global Meningococcal Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    6.1. North America
    6.1.1. North America Meningococcal Vaccine Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
    6.2. Europe
    6.2.1. Europe Meningococcal Vaccine Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Rest of Europe
    6.3. Asia-Pacific
    6.3.1. Asia-Pacific Meningococcal Vaccine Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia
    6.4. Latin America
    6.4.1. Latin America Meningococcal Vaccine Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
    6.5. Middle East and Africa
    6.5.1. Middle East and Africa Meningococcal Vaccine Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
  - 7. Global Meningococcal Vaccine Market Competitive Landscape, Market Share Analysis, and Company Profiles
    7.1. Market Share Analysis
    7.2. Company Profiles
    7.3. Novartis
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
    7.4. GSK
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
    7.5. Merck
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
    7.6. CSL
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
    7.7. Baxter
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
    7.8. JN International Medical Corporation
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
    7.9. Serum Institute of India
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
    7.10. Bio-Med
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
    7.11. China National Biotec Group
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. Hualan Bio
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
    7.13. Walvax
    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments
    7.14. Zhifei
    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments
  - 8. Assumptions and Acronyms
  - 9. Research Methodology
  - 10. Contact
- Novartis AG Company Profile
- GSK
- Merck KGaA Company Profile
- CSL
- Baxter International Inc Company Profile
- JN International Medical Corporation
- Serum Institute of India
- Bio-Med
- China National Biotec Group
- Hualan Bio
- Walvax
- Zhifei
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)